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Pneumatosis intestinalis is a rare disorder characterized by gas-ﬁlled cysts within the subserosal and/or submucosal regions of the
intestinal wall. The source of this gas and its translocation across the mucosa is incompletely understood. Most (85%) cases are
associated with medical conditions, ranging from psychiatric through respiratory disorders to gastrointestinal-related diseases; the
remaining 15% lack any recognizable cause or association. In this case report, pneumatosis coli (aﬀecting the colon) occurred in
a patient following abdominal surgery and was associated with pseudomembranous colitis, which was Clostridium diﬃcile toxin
negative—presumably a false negative. Supportive care and appropriate antibacterial agents suﬃced to alleviate symptoms and
resolve the pneumatosis. Recognizing this uncommon but important association can avoid high ﬁnancial and personal costs from
unnecessary testing and invasive surgical explorations. Consideration should be given to pseudomembranous colitis as the basis
for pneumatosis coli developing in patients who have received antibiotics, once gut ischemia has been ruled out.
1.Introduction
Pneumatosis intestinalis (PI) is characterized by multi-
ple, thin-walled, gas-ﬁlled cysts within the subserosal and
submucosal regions of the intestinal wall. Typically the
location of pneumatosis is 46% in the colon, 27% small
bowel, 5% stomach (usually termed gastric pneumatosis),
and 7% involving both the small and large intestine [1].
Its pathogenesis is not completely understood. 15% of
cases are primary or idiopathic, without identiﬁable cause
or association. 85% of cases are associated with a wide
variety of medical conditions and infections, suggesting a
number of potential underlying pathogenic processes that
may contribute to its development, that is, as a secondary
event [2]. When limited to the colon, such collections of
intramural gas are termed pneumatosis coli (PC).
We report a case of PC in a patient following colonic
surgery, which was diagnosed as pseudomembranous colitis
and successfully treated for a toxin-negative Clostridium
diﬃcile infection.
2. Case Presentation
A 56-year-old male with recently diagnosed rectal carcinoma
(T1N0M0) underwent a low anterior resection and diversion
ileostomythatwasfollowedfourweekslaterbyanuncompli-
cated loop ileostomy closure. Within a week of this reversal
surgery, he was readmitted with nausea, vomiting, anorexia,
anddiﬀuseabdominalpain,alongwith6–8nonbloody,small
volume, liquid bowel movements daily. The patient had
not been taking proton pump inhibitors, but had received
ceftazidime and gentamicin with his recent surgeries. He
appeared unwell on admission with nonspeciﬁc abdominal
tenderness upon palpation; bowel sounds were normal. His
hemoglobin was 130g/dL, platelet count 416 × 109/L, and
white blood cell count 6.7 × 109/L. Electrolytes, including
bicarbonate, and creatinine were also within normal limits.
The initial stool collections, were negative for the C. diﬃcile
cytotoxin assay (C. diﬃcile Tox A/B II (Techlab, Blacksburg,
VA)), bacterial culture, and ova/parasites. Abdominal X-rays
revealed distended loops of large bowel with mural edema.2 Case Reports in Medicine
Figure 1: Abdominal computed tomography (CT) revealing sub-
mucosal air-ﬂuid cysts. Arrows demarcate submucosal gas within
the wall of the left colon, pneumatosis coli.
Subsequent abdominal computerized tomography (CT)
demonstrated extensive pneumatosis coli (Figure 1)i n v o l v -
ing the descending colon; there was also thumb printing and
dilated loops of bowel. The patient was initially placed on
metronidazole 500mgIV q8h for three days due to concern
regarding the clinical suspicion for a Clostridium diﬃcile
associated diarrheal (CDAD) infection. The intravenous
route was chosen because of the postsurgical ileus with
abdominal distension, reduced bowel sounds, and inability
to tolerate oral feeds. A mild metabolic alkalosis was present
on blood gas but there was no evidence of acidosis that
might have suggested a gut ischemia. Flexible sigmoidoscopy
clinically conﬁrmed the diagnosis, showing quite classical
pseudomembranes in addition to features consistent with
pneumatosis intestinalis (Figure 2). Biopsies revealed a focal
active colitis with superﬁcial ulceration, gland destruction,
and areas in which exudates overlay the colonic mucosa,
all supporting the diagnosis of pseudomembranous colitis.
Two subsequent C. diﬃcile toxin assays however proved
negative. The intravenous metronidazole was then changed
to oral vancomycin at 125mg four times daily for four
days. The patient improved over the subsequent week with
a reduction in the frequency of bowel motions and a
marked improvement in abdominal discomfort. Follow-up
abdominal CT scan 8 days after the initial study revealed
resolution of the pneumatosis coli. Discharged thereafter, he
remained well without a recurrence of either entity; his last
colonoscopy was normal 7 months following discharge.
3. Discussion
3.1. Epidemiology. Pneumatosis intestinalis, rather than
being a disease per se, better relates to the underlying patho-
logicalprocess thatvaries widely:frombeing quiteincidental
without symptoms detected on screening colonoscopy to
Figure 2: Pseudomembranes and pneumatosis coli. Endoscopic
evaluation of the colonic mucosa reveals pseudomembranes. Cystic
lesions are evident beneath the pseudomembranous layer.
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Figure 3: Colonic biopsy (10x) showing changes with exudate
and ulceration (arrows) that are typical of the pseudomembrane
f o r m a t i o ns e e ni np s e u d o m e m b r a n o u sc o l i t i s .
being associated with life-threatening conditions, such as
necrotizing enterocolitis in infants or ischemic/infracted
bowel in adults [3]. Though a rare event, pneumatosis
has historically mandated surgical exploration and was
associated with a high mortality rate (33%), mostly reported
as small case series [1] .Am o r er e c e n ts t u d yt h a tr e v i e w e d
25,000 CT scans done over a 7-year period identiﬁed a
prevalence of PI in 0.37% of patients [1]. Approximately
50% of these patients however were successfully managed
nonoperatively. As many cases of pneumatosis are incidental
ﬁndings detected on diagnostic imaging, its true frequency
must be underestimated.
3.2. Clinical Associations. PI in adults is typically divided
into primary (15% of cases being idiopathic, lacking any
identiﬁable association) and secondary (85%) forms with
diverse clinical associations, including psychiatric disorders,Case Reports in Medicine 3
respiratory conditions, dementia, inﬂammatory bowel dis-
ease, diverticular disease, redundant sigmoid colon, appen-
dicitis, peptic ulcer disease, and within the past decade,
bacterial infections like C. diﬃcile [4–6]. PI aﬀecting infants
is life-threatening, occurring in the setting of necrotizing
e n t e r o c o l i t i sa sw e l la sP Ct h a tu s u a l l yp r e s e n t sa sam i l d e r
form of this entity [7].
3.3. Pathophysiology. These multiple, gas-ﬁlled cysts (actu-
allypseudocysts:spaceswithoutadistinctiveepithelialmem-
brane) develop in the intestinal submucosa and subserosa,
presumably by air or gas translocating into the bowel wall
[8, 9]. A mechanical theory raises the concept of mucosal
disruption through direct trauma or increased intraluminal
pressure, permitting intraluminal gas to dissect directly into
the submucosa or track via mesenteric vessels into the
subserosa [8]. Such mucosal disruption could result from
an endoscopic procedure, a perforated ulcer, inﬂammatory
bowel disease, necrotizing enterocolitis, intestinal ischemia,
diverticulosis, and after intestinal anastamosis, all associated
with the development of pneumatosis. Nevertheless, there
has been no documented anatomic connection between
the mucosa and the cysts. A pulmonic theory invokes
rupture of a pulmonary bleb though increased intrathoracic
pressures (e.g., coughing), allowing air to transect through
the mediastinum into the retroperitoneum, the perivascular
spacesand thencethesubserosa.Unexplained arethepaucity
of reports showing mediastinal air on diagnostic imaging
[10]. Furthermore, a bacterial theory suggests that luminal
bacteria enhance gas production (e.g., hydrogen gas from
fermented carbohydrates) and this endogenous gas then
diﬀuses across the mucosa [8]. In animal models, introduc-
tion of gas-forming bacteria can induce PC [11–14], which
resolves with subsequent antibiotic therapy [12, 13, 15]. This
mechanism however would presumably only explain PC, as
opposed to PI, because hydrogen-producing bacteria reside
in the colon and not the small bowel.
3.4. Clinical Presentation. The clinical picture can be quite
varied depending on the underlying etiology and if any
complications have transpired relative to the pneumatosis.
The spectrum of pneumatosis nevertheless does include
abdominal sepsis and death, often associated with evidence
ofportalvenousgas[1,2,16].Mostcommonly,patientshave
diarrhea, mucus discharge, rectal bleeding, and constipation
[6]. Complications associated with PC include pneumoperi-
toneum, volvulus, intestinal obstruction, perforation and
intussusception. In infants, pneumatosis intestinalis that
develops secondarily to necrotizing enterocolitis culminates
in a high mortality rate.
3.5.Diagnosis. Investigationsshouldstartwithplainabdom-
inalX-raysthatmayrevealcomplicationsrelatedtoPC;these
are present in 23% [1]. Such ﬁndings include radiolucent
clusters, linear streaks, or small bubbles along the bowel wall.
If a cyst ruptures, a pneumoperitoneum develops. Barium
enema might demonstrate the gas-ﬁlled cysts in the wall of
the colon, but is not routinely ordered. Instead, CT imaging
typically follows the abdominal X-ray in clinical practice. CT
accurately identiﬁes the bubble-like collections of gas within
the submucosal and subserosal layers of the colonic mucosa.
Evidence of pneumatosis when combined with prominent
portomesenteric venous gas represents ominous ﬁndings,
suggesting transmural bowel infarction. These impressive
radiologic features however are not absolute prognostic
indicators as CT imaging detects pneumatosis at a relatively
earlystagethatmayonlysignifypartialmuralbowelischemia
[16]. Care must be taken to also diﬀerentiate bubble-like PI
from pneumatosis linearis: bands of gas within the bowel
wall that place here associated with loss of gut viability,
prompting urgent surgery. Ultimately an endoscopic evalua-
tion may become necessary to diﬀerentiate PC from familial
adenomatous polyposis and colonic malignancies. Intestinal
biopsies in PI characteristically reveal gas-ﬁlledspaces within
the submucosa that on histopathology are lined with his-
tiocytes and multinucleated giant cells when involving the
subserosa.
3.6. Diagnosis of Clostridium Diﬃcile Infection. Key in man-
aging PC is to identify a correctable etiology. In the present
case, suspicion of a Clostridium diﬃcile infection (CDI)
arose because watery diarrhea had developed in a recently
hospitalized patient who had received antibacterial agents
[17, 18]. (Watery diarrhea in this context has been deﬁned
as ≥3 stools per day that are suﬃciently liquid to conform to
the shape of its laboratory container [16, 17]). The diagnosis
ofpseudomembranouscolitishowevercamefromdiagnostic
imaging,theendoscopyshowingpseudomembranes,andthe
characteristic histopathology ﬁndings. Our patient had C.
diﬃcile toxin assays that were negative on three separate
occasions.
C. diﬃcile is a gram positive, rod-shaped bacterium. CDI
results from pathogenic strains that are capable of producing
two structurally similar toxins: A and B. Both are important
in producing C. diﬃcile colitis: toxin A being considered
enterotoxigenic whereas toxin B has potent cytotoxic eﬀects
[19]. Hence, the laboratory diagnosis comes in two formats:
(1) Toxin assays for one or both toxins, or for the cytotoxic
eﬀect, and (2) Microorganism assays to test for a common
antigen or perform an anaerobic stool culture for C. diﬃcile.
Commercially available enzyme immunoassays (EIAs) are
capable of detecting both toxin A and toxin B, important
as occasionally some strains produce only A or only B.
[20]. Although EIAs are rapid, inexpensive, and yield high
speciﬁcity (up to 99%), their rather modest sensitivity (32–
73%) results in a high false negative rate [18]. Repeating
the stool EIA, as was done here when the initial test was
negative, may improve sensitivity but only slightly (∼10%).
Re-ordering such stool tests moreover ultimately reduces
speciﬁcity to unacceptable levels [17, 18]. More sensitive
polymer chain reaction (PCR) assays for the toxin genes,
recentadditions,providehighsensitivityintheorderof97%.
Lastly, tissue culture to detect cell cytotoxicity is costly and
impractical despite being a “gold” standard for diagnosing
C. diﬃcile.
The second category checks for the presence of the
organism. Common antigen testing seeks to detect the
enzyme, glutamate dehydrogenase (GDH), that C. diﬃcile4 Case Reports in Medicine
produces [21]. EIA assays for GDH carry a high sensitivity
(85–95%) while ensuring a high negative predictive value
[21]. The GDH assay (like the cumbersome anaerobic stool
culture) unfortunately also detects non-toxigenic and hence
clinically irrelevant isolates. A strategy suggested by the 2010
IDSA guidelines on C. diﬃcile supports a two step method:
EIA to detect GDH as the initial screen (which is most sen-
sitive), followed by a cell cytotoxicity assay, toxigenic culture
or PCR for the toxin gene as the conﬁrmatory test for GDH-
positive specimens only, hence eliminating false-positive
GDH results [21]. Culturing for C. diﬃcile may be sensitive
(over 90%), but is not practical as a routine diagnostic test
since the results require 48–72 hours to complete. Further,
anaerobic stool culture does not diﬀerentiate between toxin-
producingandnon-toxigenicstrains.Cultureisbestreserved
for epidemiologic, infection control or antibacterial studies.
As no test combination to date is 100% sensitive and
speciﬁc, endoscopy is an important diagnostic tool. Mor-
phological diagnosis, as was necessary in this diﬃcult case,
came from the endoscopic picture and biopsy. Nevertheless,
pseudomembranes are only detected endoscopically in about
50% of CDAD cases, as conﬁrmed by both stool culture and
cytotoxin stool test positivity [22]. Conversely, the presence
of pseudomembranes must be taken in the clinical context,
being neither absolutely sensitive nor speciﬁc for C. diﬃcile
colitis; pseudomembranes can accompany ischemic colitis
and inﬂammatory bowel disease.
Some endoscopic similarities exist between ischemic col-
itis and CDI-associated pseudomembranous colitis, further
complicating such diﬃcult acute abdominal diagnoses. In
ischemic colitis, however, any pseudomembranes tend to be
more diﬀuse and have transmural involvement, compared
to C. diﬃcile colitis. Further, the histological presence of
atrophic microcrypts, lamina propria hemorrhage, full-
thickness necrosis and hyalinized lamina propria are speciﬁc
markers for ischemia [23].
The diagnosis of pseudomembranous colitis in the
current case is secure from the endoscopic and morpho-
logical perspectives. The presence of pseudomembranous
colitis is strongly suggestive of toxigenic C. diﬃcile infection
regardless of the results of toxin EIA despite the absence of
backuptests,suchascytotoxicity,culture,orPCR.Therefore,
one of two conclusions is possible. (1) This was a toxigenic
infection with a false-negative EIA—most likely, or (2) this
was an extremely rare case of pseudomembranous colitis due
to a cause other than C. diﬃcile.
3.7. Prognosis and Management. T h ec o u r s eo fp n e u m a t o s i s
isquitevariable,largelydeterminedbytheunderlyingdisease
process, especially those leading to bowel infraction or
perforation. Traditionally, a diagnosis of PI was associated
with a high mortality rate and mandated aggressive surgical
intervention. In fact, the clinical course is generally quite
benign: most (∼50%) cases of PI spontaneously resolve,
particularly when idiopathic. Regardless of PI location or
intervention, there remains a signiﬁcant mortality at 20%–
40%, emphasizing the need to diﬀerentiate between sinister
gut ischemia and rather benign PI [1]. Hence, interventions
for imaging-diagnosed PI generally may be categorized as (a)
operative (about 1/3rd), (b) nonoperative (∼1/2), and (c)
futile (∼15%), favoring non-surgical management such as
inserting a nasogastric tube supported by IV ﬂuids.
The key decision therefore is whether to perform an
emergency laparotomy for an acute intra-abdominal catas-
trophe or to manage the case conservatively for rather
benign PI. A quite reasonable guide to identify gut infarction
and the need for surgical intervention is a clinical setting
that suggests an acute abdomen, laboratory evidence of a
metabolic acidosis (particularly lactic acidosis) and elevated
amylase,anddiagnosticimagingshowinglinearpneumatosis
and/or portal venous gas [24].
Speciﬁc treatment is best directed at the underlying
disease process. For those with symptoms, management
strategies directed at the pneumatosis itself have used (1)
Oxygen therapy (either by inhalation or as hyperbaric
therapy, the latter to reduce toxicity) for several days to
impede anaerobic bacteria that produce the hydrogen and
other gases in these cysts, and to replace these gases [11];
(2) antibacterial agents (like metronidazole) 7 days for up
to 2-3 months to decrease bacterial gas production [12, 25];
(3) elemental diet for 2 weeks, seeking to alter the colonic
microﬂora [26]. Colonic resection is occasionally necessary
for complications like bowel obstruction. For the majority
without symptoms, an expectant approach is all that is
necessary because the intramural gas should resolve with
time.
Acknowledgments
The authors appreciate the histopathological expertise pro-
vided by Dr. Anna Sienko, Department of Pathology, the
advice oﬀered by Dr. Shane Devlin in preparing this paper,
and the valued microbiological information supplied by
Drs. Dan Gregson and Thomas Louis, Division of Medical
Microbiology, Departments of Medicine and Pathology
& Laboratory Medicine, University of Calgary, Calgary,
Alberta.
References
[1] M. S. Morris, A. C. Gee, S. D. Cho et al., “Management
and outcome of pneumatosis intestinalis,” American Journal of
Surgery, vol. 195, no. 5, pp. 679–683, 2008.
[2] L. G. Koss, “Abdominal gas cysts (pneumatosis cystoides
intestinorum hominis); an analysis with a report of a case
and a critical review of the literature,” American Architect
Pathology, vol. 53, no. 6, pp. 523–549, 1952.
[3] Y. Heng, M. D. Schuﬄe r ,R .C .H a g g i t t ,a n dC .A .R o h r m a n n ,
“Pneumatosis intestinalis: a review,” American Journal of
Gastroenterology, vol. 90, no. 10, pp. 1747–1758, 1995.
[4] C. Kreiss, F. Forohar, A. E. Smithline, and L. J. Brandt, “Pneu-
matosis intestinalis complicating C. diﬃcile pseudomembra-
nous colitis,” American Journal of Gastroenterology, vol. 94, no.
9, pp. 2560–2561, 1999.
[5] P. Schenk, C. Madl, L. Kramer et al., “Pneumatosis intestinalis
with Clostridium diﬃcile colitis as a cause of acute abdomen
afterlungtransplantation,”DigestiveDiseasesandSciences,vol.
43, no. 11, pp. 2455–2458, 1998.Case Reports in Medicine 5
[6] G. Gagliardi, I. W. Thompson, M. J. Hershman, A. Forbes, P.
R. Hawley, and I. C. Talbot, “Pneumatosis coli: a proposed
pathogenesis based on study of 25 cases and review of the
literature,” International Journal of Colorectal Disease, vol. 11,
no. 3, pp. 111–118, 1996.
[7] J. C. Leonidas and R. T. Hall, “Neonatal pneumatosis coli:
a mild form of neonatal necrotizing enterocolitis,” Journal of
Pediatrics, vol. 89, no. 3, pp. 456–459, 1976.
[ 8 ]S .U .C h r i s t l ,G .R .G i b s o n ,P .R .M u r g a t r o y d ,W .S c h e p p a c h ,
and J. H. Cummings, “Impaired hydrogen metabolism in
pneumatosis cystoides intestinalis,” Gastroenterology, vol. 104,
no. 2, pp. 392–397, 1993.
[9] M. D. Levitt and S. Olsson, “Pneumatosis cystoides intestinalis
and high breath H2 excretion: insights into the role of H2 in
this condition,” Gastroenterology, vol. 108, no. 5, pp. 1560–
1565, 1995.
[10] N. Gull` a, V. Castagna, V. Dei Santi et al., “Pneumoretrop-
eritoneum caused by pneumatosis cystoides intestinalis.
Etiopathogenethical clinical and diagnostic considerations.
Report of a clinical case,” Minerva Chirurgica, vol. 53, no. 9,
pp. 757–765, 1998.
[11] H. H. Stone, W. B. Allen, R. B. Smith III, and C. D.
Haynes, “Infantile pneumatosis intestinalis,” Journal of Surgi-
cal Research, vol. 8, no. 7, pp. 301–307, 1968.
[12] S. Holt, H. M. Gilmour, and T. A. S. Buist, “High ﬂow oxygen
therapy for pneumatosis coli,” Gut, vol. 20, no. 6, pp. 493–498,
1979.
[13] J. Wandtke, J. Skucas, R. Spataro, and R. J. Bruneau, “Pneu-
matosis intestinalis as a complication of jejunoileal bypass,”
American Journal of Roentgenology, vol. 129, no. 4, pp. 601–
604, 1977.
[14] S. D. St. Peter, M. A. Abbas, and K. A. Kelly, “The spectrum of
pneumatosis intestinalis,” Archives of Surgery, vol. 138, no. 1,
pp. 68–75, 2003.
[15] A. Al-Talib, F. Al-Ghtani, and R. Munk, “Pneumatosis
Intestinalis: can we avoid surgical intervention in nonsurgical
patients?” Case Reports in Gastroenterology, vol. 3, pp. 286–
292, 2009.
[16] W. Wiesner, K. J. Mortel´ e, J. N. Glickman, H. Ji, and P. R.
Ros, “Pneumatosis intestinalis and portomesenteric venous
gas in intestinal ischemia: correlation of CT ﬁndings with
severity of ischemia and clinical outcome,” American Journal
of Roentgenology, vol. 177, no. 6, pp. 1319–1323, 2001.
[17] T. Planche, A. Aghaizu, R. Holliman et al., “Diagnosis of
Clostridium diﬃcile infection by toxin detection kits: a
systematic review,” T h eL a n c e tI n f e c t i o u sD i s e a s e s , vol. 8, no.
12, pp. 777–784, 2008.
[18] L. R. Peterson and A. Robicsek, “Does my patient have
Clostridium diﬃcile infection?” Annals of Internal Medicine,
vol. 151, no. 3, pp. 176–179, 2009.
[19] D. Lyras, J. R. O’Connor, P. M. Howarth et al., “Toxin B is
essential for virulence of Clostridium diﬃcile,” Nature, vol.
458, no. 7242, pp. 1176–1179, 2009.
[20] D. Drudy, S. Fanning, and L. Kyne, “Toxin A-negative,
toxin B-positive Clostridium diﬃcile,” International Journal of
Infectious Diseases, vol. 11, no. 1, pp. 5–10, 2007.
[21] S. H. Cohen, D. N. Gerding, S. Johnson et al., “Clinical
practic guidelines for clostridium diﬃcile infection in adults:
2010 update by the society for healthcare epidemiology of
america (SHEA) and the infectious diseases society of america
(IDSA),” Infection Control Hospital Epidemiology, vol. 31, no.
5, pp. 431–455, 2010.
[22] D. N. Gerding, M. M. Olson, and L. R. Peterson, “Clostridium
diﬃcile-associateddiarrheaandcolitisinadults.Aprospective
case-controlled epidemiologic study,” Archives of Internal
Medicine, vol. 146, no. 1, pp. 95–100, 1986.
[23] C. R. Dignan and J. K. Greenson, “Can ischemic colitis be
diﬀerentiated from C diﬃcile colitis in biopsy specimens?”
American Journal of Surgical Pathology, vol. 21, no. 6, pp. 706–
710, 1997.
[24] S. J. Knechtle, A. M. Davidoﬀ, and R. P. Rice, “Pneumatosis
intestinalis. Surgical management and clinical outcome,”
Annals of Surgery, vol. 212, no. 2, pp. 160–165, 1990.
[ 2 5 ]N .A d e - A j a y i ,P .V e y s ,M .S t a n t o n ,D .P .D r a k e ,a n dA .
Pierro,“Conservativemanagementofpneumatosisintestinalis
and pneumoperitoneum following bone-marrow transplanta-
tion,” Pediatric Surgery International, vol. 18, no. 8, pp. 692–
695, 2002.
[26] B. T. Johnston and R. J. McFarland, “Elemental diet in
the treatment of pneumatosis coli,” Scandinavian Journal of
Gastroenterology, vol. 30, no. 12, pp. 1224–1227, 1995.